UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000025699
Receipt No. R000029565
Scientific Title Effect of Lutein, Zeaxanthin supplements on human.
Date of disclosure of the study information 2018/03/15
Last modified on 2018/07/09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of Lutein, Zeaxanthin supplements on human.
Acronym Lutein Zeaxanthin clinical trial
Scientific Title Effect of Lutein, Zeaxanthin supplements on human.
Scientific Title:Acronym Lutein Zeaxanthin clinical trial
Region
Japan

Condition
Condition Healthy people
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effect of Lutein, Zeaxanthin supplements on human.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes contrast sensitivity
Accommodation ability
Key secondary outcomes Visual Analog Scale

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Lutein,Zeaxanthin supplements
2 capsule/day
Interventions/Control_2 Placebo supplements
2 capsule/day
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria (1) persons who will generally be judged as healthy
(2) Persons who will give written informed consent by theirselves
Key exclusion criteria (1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficay with the effect evaluated in this study
(2) persons who changed their habitats of supplements whitin 4 weeks.
(3) Persons who work in night shift or in day and night shift
(4) persons who have been treated their illness or prevention in a clinic at their informed consent
(5) persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system
(6) persons with the medical histories of alcoholism or drug dependence
(7) persons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study preiod
(9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) persons who will not be judged suitable to the participants by the investigator.
Target sample size 40

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kuniyoshi Shimizu
Organization Faculty of Agriculture, Kyushu University
Division name Laboratory of Systematic Forest and Forest Products Science
Zip code
Address 6-10-1 Hakozaki, Higashi-ku, Fukuoka
TEL 092-642-3002
Email shimizu@agr.kyushu-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kuniyoshi Shimizu
Organization Faculty of Agriculture, Kyushu University
Division name Laboratory of Systematic Forest and Forest Products Science
Zip code
Address 6-10-1 Hakozaki, Higashi-ku, Fukuoka
TEL 092-642-3002
Homepage URL
Email shimizu@agr.kyushu-u.ac.jp

Sponsor
Institute Laboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University
Institute
Department

Funding Source
Organization Stella Sasaki Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Fuculuty of Humanity-Oriented Science and Eingineering, Kindai University
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 03 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 11 Month 28 Day
Date of IRB
Anticipated trial start date
2017 Year 01 Month 16 Day
Last follow-up date
2017 Year 03 Month 25 Day
Date of closure to data entry
2017 Year 04 Month 07 Day
Date trial data considered complete
2017 Year 04 Month 26 Day
Date analysis concluded
2017 Year 05 Month 29 Day

Other
Other related information

Management information
Registered date
2017 Year 01 Month 16 Day
Last modified on
2018 Year 07 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029565

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.